Rheumatoid arthritis: A role for immunosenescence?

Journal of the American Geriatrics Society

Volumn 58, Issue 8, 2010, Pages 1565-1575

  Lindstrom, Tamsin M ^a,b   Robinson, William H ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aging; autoimmunity; CD28; immunosenescence; rheumatoid arthritis

Indexed keywords

ADAPTIVE IMMUNITY; AGING; AUTOIMMUNITY; B LYMPHOCYTE; CELL DEGENERATION; CELL SURVIVAL; COMPLEMENT FACTOR; DENDRITIC CELL; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; NATURAL KILLER CELL; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ADAPTIVE IMMUNITY; AGING; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNE SYSTEM; LEUKOCYTE COUNT; T-LYMPHOCYTES;

EID: 77955236931     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02965.x     Document Type: Review

References (89)

1. Doran MF, Pond GR, Crowson CS et al. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002 46 : 625 631.
2. Pedersen JK, Svendsen AJ, Horslev-Petersen K. Incidence of rheumatoid arthritis in the southern part of Denmark from 1995 to 2001. Open Rheumatol J 2007 1 : 18 23.
3. Riise T, Jacobsen BK, Gran JT. Incidence and prevalence of rheumatoid arthritis in the county of Troms, northern Norway. J Rheumatol 2000 27 : 1386 1389.
4. Symmons DP, Barrett EM, Bankhead CR et al. The incidence of rheumatoid arthritis in the United Kingdom: Results from the Norfolk Arthritis Register. Br J Rheumatol 1994 33 : 735 739.
5. Baecklund E, Iliadou A, Askling J et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006 54 : 692 701.
6. Doran MF, Crowson CS, Pond GR et al. Frequency of infection in patients with rheumatoid arthritis compared with controls: A population-based study. Arthritis Rheum 2002 46 : 2287 2293.
7. Colmegna I, Diaz-Borjon A, Fujii H et al. Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum 2008 58 : 990 1000.
8. Koetz K, Bryl E, Spickschen K et al. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 2000 97 : 9203 9208.
9. Schmidt D, Goronzy JJ, Weyand CM. CD4+CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996 97 : 2027 2037.
10. Wagner UG, Koetz K, Weyand CM et al. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci U S A 1998 95 : 14447 14452.
11. Valenzuela HF, Effros RB. Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin Immunol 2002 105 : 117 125.
12. Vallejo AN. CD28 extinction in human T cells: Altered functions and the program of T-cell senescence. Immunol Rev 2005 205 : 158 169.
13. Weng NP, Akbar AN, Goronzy J. CD28(-) T cells: Their role in the age-associated decline of immune function. Trends Immunol 2009 30 : 306 312.
14. Goldrath AW, Bevan MJ. Selecting and maintaining a diverse T-cell repertoire. Nature 1999 402 : 255 262.
15. Boesteanu AC, Katsikis PD. Memory T cells need CD28 costimulation to remember. Semin Immunol 2009 21 : 69 77.
16. van der Helm-van Mil AH, Wesoly JZ, Huizinga TW. Understanding the genetic contribution to rheumatoid arthritis. Curr Opin Rheumatol 2005 17 : 299 304.
17. Thomas R, McIlraith M, Davis LS et al. Rheumatoid synovium is enriched in CD45RBdim mature memory T cells that are potent helpers for B cell differentiation. Arthritis Rheum 1992 35 : 1455 1465.
18. Panayi GS. Even though T-cell-directed trials have been of limited success, is there reason for optimism? Nat Clin Pract Rheumatol 2006 2 : 58 59.
19. Schroder AE, Greiner A, Seyfert C et al. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci U S A 1996 93 : 221 225.
20. Rantapaa-Dahlqvist S, de Jong BA, Berglin E et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003 48 : 2741 2749.
21. Khachigian LM. Collagen antibody-induced arthritis. Nat Protoc 2006 1 : 2512 2516.
22. Uysal H, Bockermann R, Nandakumar KS et al. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med 2009 206 : 449 462.
23. Edwards JC, Szczepanski L, Szechinski J et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004 350 : 2572 2581. (Pubitemid 38758544)
24. Lebre MC, Tak PP. Dendritic cells in rheumatoid arthritis: Which subset should be used as a tool to induce tolerance? Hum Immunol 2009 70 : 321 324.
25. Leung BP, Conacher M, Hunter D et al. A novel dendritic cell-induced model of erosive inflammatory arthritis: Distinct roles for dendritic cells in T cell activation and induction of local inflammation. J Immunol 2002 169 : 7071 7077.
26. McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 2007 7 : 429 442.
27. Goronzy JJ, Weyand CM. Rheumatoid arthritis. Immunol Rev 2005 204 : 55 73.
28. Klareskog L, Padyukov L, Ronnelid J et al. Genes, environment and immunity in the development of rheumatoid arthritis. Curr Opin Immunol 2006 18 : 650 655.
29. de Pablo P, Chapple IL, Buckley CD et al. Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol 2009 5 : 218 224.
30. Goronzy JJ, Lee WW, Weyand CM. Aging and T-cell diversity. Exp Gerontol 2007 42 : 400 406.
31. Vaziri H, Dragowska W, Allsopp RC et al. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci U S A 1994 91 : 9857 9860.
32. Muller-Sieburg C, Sieburg HB. Stem cell aging: Survival of the laziest? Cell Cycle 2008 7 : 3798 3804.
33. Cho RH, Sieburg HB, Muller-Sieburg CE. A new mechanism for the aging of hematopoietic stem cells: Aging changes the clonal composition of the stem cell compartment but not individual stem cells. Blood 2008 111 : 5553 5561.
34. Hakim FT, Memon SA, Cepeda R et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J Clin Invest 2005 115 : 930 939.
35. Ernst B, Lee DS, Chang JM et al. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 1999 11 : 173 181.
36. Goldrath AW, Bevan MJ. Low-affinity ligands for the TCR drive proliferation of mature CD8+T cells in lymphopenic hosts. Immunity 1999 11 : 183 190.
37. Goronzy JJ, Weyand CM. Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol 2001 22 : 251 255.
38. Czesnikiewicz-Guzik M, Lee WW, Cui D et al. T cell subset-specific susceptibility to aging. Clin Immunol 2008 127 : 107 118.
39. Posnett DN, Sinha R, Kabak S et al. Clonal populations of T cells in normal elderly humans: The T cell equivalent to "benign monoclonal gammapathy J Exp Med 1994 179 : 609 618.
40. Weyand CM, Brandes JC, Schmidt D et al. Functional properties of CD4+CD28- T cells in the aging immune system. Mech Ageing Dev 1998 102 : 131 147.
41. Vallejo AN, Schirmer M, Weyand CM et al. Clonality and longevity of CD4+CD28null T cells are associated with defects in apoptotic pathways. J Immunol 2000 165 : 6301 6307.
42. Spaulding C, Guo W, Effros RB. Resistance to apoptosis in human CD8+T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. Exp Gerontol 1999 34 : 633 644.
43. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999 285 : 727 729.
44. Verneris MR, Karami M, Baker J et al. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+T cells. Blood 2004 103 : 3065 3072.
45. Chiu WK, Fann M, Weng NP. Generation and growth of CD28nullCD8+memory T cells mediated by IL-15 and its induced cytokines. J Immunol 2006 177 : 7802 7810.
46. Thewissen M, Somers V, Hellings N et al. CD4+CD28null T cells in autoimmune disease: Pathogenic features and decreased susceptibility to immunoregulation. J Immunol 2007 179 : 6514 6523.
47. Vasto S, Colonna-Romano G, Larbi A et al. Role of persistent CMV infection in configuring T cell immunity in the elderly. Immun Ageing 2007 4 : 2.
48. van Leeuwen EM, Remmerswaal EB, Vossen MT et al. Emergence of a CD4+CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 2004 173 : 1834 1841.
49. Weyand CM, Goronzy JJ. Premature immunosenescence in rheumatoid arthritis. J Rheumatol 2002 29 : 1141 1146.
50. Fujii H, Shao L, Colmegna I et al. Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci U S A 2009 106 : 4360 4365.
51. Schonland SO, Lopez C, Widmann T et al. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci U S A 2003 100 : 13471 13476.
52. Thewissen M, Somers V, Venken K et al. Analyses of immunosenescent markers in patients with autoimmune disease. Clin Immunol 2007 123 : 209 218.
53. Lorenzi AR, Morgan TA, Anderson A et al. Thymic function in juvenile idiopathic arthritis. Ann Rheum Dis 2009 68 : 983 990.
54. Prelog M, Schwarzenbrunner N, Sailer-Hock M et al. Premature aging of the immune system in children with juvenile idiopathic arthritis. Arthritis Rheum 2008 58 : 2153 2162.
55. Kapoor S, Wilson AG, Sharrack B et al. Haemopoietic stem cell transplantation-an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology. Hematology 2007 12 : 179 191.
56. Park JI, Venteicher AS, Hong JY et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 2009 460 : 66 72.
57. Park W, Weyand CM, Schmidt D et al. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells. Eur J Immunol 1997 27 : 1082 1090.
58. Martens PB, Goronzy JJ, Schaid D et al. Expansion of unusual CD4+T cells in severe rheumatoid arthritis. Arthritis Rheum 1997 40 : 1106 1114.
59. Nadareishvili ZG, Li H, Wright V et al. Elevated pro-inflammatory CD4+CD28- lymphocytes and stroke recurrence and death. Neurology 2004 63 : 1446 1451.
60. Davila E, Kang YM, Park YW et al. Cell-based immunotherapy with suppressor CD8+T cells in rheumatoid arthritis. J Immunol 2005 174 : 7292 7301.
61. van den Berg WB, Miossec P. IL-17 as a future therapeutic target for rheumatoid arthritis. Nat Rev Rheumatol 2009 5 : 549 553.
62. Eaton SM, Burns EM, Kusser K et al. Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med 2004 200 : 1613 1622.
63. Davey FR, Huntington S. Age-related variation in lymphocyte subpopulations. Gerontology 1977 23 : 381 389.
64. Kline GH, Hayden TA, Klinman NR. B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J Immunol 1999 162 : 3342 3349.
65. Goidl EA, Innes JB, Weksler ME. Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice. J Exp Med 1976 144 : 1037 1048.
66. Zharhary D, Klinman NR. Antigen responsiveness of the mature and generative B cell populations of aged mice. J Exp Med 1983 157 : 1300 1308.
67. Stacy S, Krolick KA, Infante AJ et al. Immunological memory and late onset autoimmunity. Mech Ageing Dev 2002 123 : 975 985.
68. Hueber W, Kidd BA, Tomooka BH et al. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 2005 52 : 2645 2655.
69. Kinloch A, Tatzer V, Wait R et al. Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis. Arthritis Res Ther 2005 7 : R1421 R1429.
70. Klareskog L, Ronnelid J, Lundberg K et al. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008 26 : 651 675. (Pubitemid 351600388)
71. Lundberg K, Nijenhuis S, Vossenaar ER et al. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 2005 7 : R458 R467.
72. Plackett TP, Boehmer ED, Faunce DE et al. Aging and innate immune cells. J Leukoc Biol 2004 76 : 291 299.
73. Ohnmacht C, Pullner A, King SB et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med 2009 206 : 549 559.
74. Jongbloed SL, Benson RA, Nickdel MB et al. Plasmacytoid dendritic cells regulate breach of self-tolerance in autoimmune arthritis. J Immunol 2009 182 : 963 968.
75. Shurin MR, Shurin GV, Chatta GS. Aging and the dendritic cell system: Implications for cancer. Crit Rev Oncol Hematol 2007 64 : 90 105.
76. Agrawal A, Tay J, Ton S et al. Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA. J Immunol 2009 182 : 1138 1145.
77. Agrawal A, Agrawal S, Cao JN et al. Altered innate immune functioning of dendritic cells in elderly humans: A role of phosphoinositide 3-kinase-signaling pathway. J Immunol 2007 178 : 6912 6922.
78. Franceschi C, Bonafe M, Valensin S et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000 908 : 244 254.
79. Boren E, Gershwin ME. Inflamm-aging: Autoimmunity, and the immune-risk phenotype. Autoimmun Rev 2004 3 : 401 406.
80. Smolen JS, Aletaha D, Koeller M et al. New therapies for treatment of rheumatoid arthritis. Lancet 2007 370 : 1861 1874.
81. Scheinecker C, Smolen J, Yasothan U et al. Nat Rev Drug Discov 2009 8 : 273 274.
82. Parish ST, Wu JE, Effros RB. Modulation of T lymphocyte replicative senescence via TNF-{alpha} inhibition: Role of caspase-3. J Immunol 2009 182 : 4237 4243.
83. Beharka AA, Meydani M, Wu D et al. Interleukin-6 production does not increase with age. J Gerontol A Biol Sci Med Sci 2001 56 : B81 B88.
84. Renshaw M, Rockwell J, Engleman C et al. Cutting edge: Impaired Toll-like receptor expression and function in aging. J Immunol 2002 169 : 4697 4701.
85. Coppe JP, Patil CK, Rodier F et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008 6 : 2853 2868.
86. Wu D, Ren Z, Pae M et al. Aging up-regulates expression of inflammatory mediators in mouse adipose tissue. J Immunol 2007 179 : 4829 4839.
87. Ramos-Casals M, Garcia-Carrasco M, Brito MP et al. Autoimmunity and geriatrics: Clinical significance of autoimmune manifestations in the elderly. Lupus 2003 12 : 341 355.
88. Nielen MM, van Schaardenburg D, Reesink HW et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum 2004 50 : 380 386.
89. Goldberg GL, Zakrzewski JL, Perales MA et al. Clinical strategies to enhance T cell reconstitution. Semin Immunol 2007 19 : 289 296.